New diabetes clinical trial: Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Published on: May 07, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Trelagliptin Succinate;   Drug: Placebo Oral Tablet
Sponsor:   CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting